HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Yongjun Zhao Selected Research
Yongjun Zhao Research Topics
Disease
28
Neoplasms (Cancer)
02/2024 - 08/2007
3
Breast Neoplasms (Breast Cancer)
12/2017 - 01/2011
3
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2017 - 11/2008
3
Neoplasm Metastasis (Metastasis)
07/2012 - 10/2009
2
Triple Negative Breast Neoplasms
01/2023 - 04/2012
2
Inflammation (Inflammations)
01/2023 - 11/2020
2
Obstructive Sleep Apnea
01/2023 - 11/2020
2
Aneuploidy (Aneuploid)
11/2019 - 09/2018
2
Lymphoma (Lymphomas)
01/2016 - 01/2015
2
B-Cell Lymphoma (Lymphoma, B Cell)
01/2016 - 06/2015
2
Leukemia
01/2012 - 11/2008
2
Infections
03/2009 - 10/2002
1
Hypertension (High Blood Pressure)
01/2023
1
Tracheal Stenosis
01/2022
1
Airway Obstruction (Choking)
01/2022
1
Respiratory Insufficiency (Respiratory Failure)
01/2022
1
COVID-19
01/2022
1
Hepatocellular Carcinoma (Hepatoma)
01/2021
1
Cardiac Arrhythmias (Arrythmia)
11/2020
1
Sarcoma (Soft Tissue Sarcoma)
12/2019
1
Tuberous Sclerosis (Bourneville's Disease)
12/2019
1
Turner Syndrome (Turner's Syndrome)
11/2019
1
Trisomy (Trisomies)
11/2019
1
Sleep Wake Disorders
01/2019
1
Alzheimer Disease (Alzheimer's Disease)
01/2019
1
Leiomyosarcoma
09/2017
1
Medulloblastoma
01/2016
1
Papillary Thyroid Cancer
12/2015
1
Anaplastic Thyroid Carcinoma
12/2015
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2015
1
Retinoblastoma (Glioblastoma, Retinal)
01/2014
1
Glioma (Gliomas)
01/2014
1
Renal Cell Carcinoma (Grawitz Tumor)
01/2014
1
Pathologic Processes
01/2014
1
Chromothripsis
12/2012
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
08/2012
1
Oligodendroglioma
01/2012
1
Stomach Neoplasms (Stomach Cancer)
01/2012
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
07/2011
1
Hodgkin Disease (Hodgkin's Disease)
03/2011
1
Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects
12/2010
1
Endometrioid Carcinoma
10/2010
1
Carcinoma (Carcinomatosis)
10/2010
Drug/Important Bio-Agent (IBA)
7
RNA (Ribonucleic Acid)
IBA
01/2021 - 09/2010
7
DNA (Deoxyribonucleic Acid)
IBA
12/2019 - 06/2009
5
Biomarkers (Surrogate Marker)
IBA
01/2023 - 01/2019
5
Proteins (Proteins, Gene)
FDA Link
01/2014 - 01/2010
4
MicroRNAs (MicroRNA)
IBA
12/2017 - 11/2008
3
Formaldehyde (Formol)
FDA Link
01/2021 - 06/2015
3
Ligands
IBA
01/2016 - 03/2011
3
Phosphotransferases (Kinase)
IBA
08/2012 - 10/2009
2
TOR Serine-Threonine Kinases
IBA
12/2019 - 01/2014
2
Cell-Free Nucleic Acids
IBA
11/2019 - 09/2018
2
Paraffin
IBA
01/2016 - 06/2015
2
MHC class II transactivator protein
IBA
06/2015 - 03/2011
2
Histones (Histone)
IBA
07/2011 - 02/2010
2
Choline (Choline Chloride)
IBA
01/2011 - 10/2009
1
Tubulin
IBA
02/2024
1
Adenosine Triphosphatases (ATPase)
IBA
02/2024
1
Phospholipid Hydroperoxide Glutathione Peroxidase
IBA
01/2023
1
Antihypertensive Agents (Antihypertensives)
IBA
01/2023
1
Tubulin Modulators
IBA
12/2022
1
Colchicine
FDA Link
Generic
12/2022
1
deoxypodophyllotoxin
IBA
12/2022
1
Indicators and Reagents (Reagents)
IBA
01/2022
1
Anesthetics (Anesthetic Agents)
IBA
01/2022
1
apatinib
IBA
01/2021
1
thiamine triphosphorate (TTP)
IBA
01/2021
1
Nucleic Acids
IBA
01/2021
1
salicylhydroxamic acid (SHAM)
IBA
11/2020
1
Therapeutic Uses
IBA
11/2020
1
Everolimus
FDA Link
12/2019
1
N-(4-isothiocyanatophenethyl)spiperone
IBA
11/2019
1
Adenosine (Adenocard)
FDA Link
Generic
01/2019
1
Circulating Tumor DNA
IBA
01/2019
1
dichlorobis(azomycin)platinum II
IBA
09/2018
1
Platinum
IBA
12/2017
1
Immune Checkpoint Inhibitors
IBA
01/2016
1
Oligonucleotides
IBA
01/2016
1
Chromatin
IBA
01/2015
1
Transcription Factors (Transcription Factor)
IBA
10/2014
1
Temozolomide (Temodar)
FDA Link
Generic
01/2014
1
Cytokine Receptors (Cytokine Receptor)
IBA
08/2012
1
Progesterone Receptors (Progesterone Receptor)
IBA
04/2012
1
Homeodomain Proteins (Proteins, Homeobox)
IBA
01/2012
1
2- (4- (3- quinolin- 6- ylmethyl- 3H- (1,2,3)triazolo(4,5- b)pyrazin- 5- yl)pyrazol- 1- yl)ethanol
IBA
01/2012
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2012
1
Tyrosine Kinase Inhibitors
IBA
01/2012
1
Proto-Oncogene Proteins c-met
IBA
01/2012
1
compound 18
IBA
01/2011
1
Deoxyglucose (2 Deoxy D glucose)
IBA
01/2011
1
fluorocholine
IBA
01/2011
1
Sterols
IBA
12/2010
Therapy/Procedure
12
Therapeutics
11/2020 - 08/2005
2
Continuous Positive Airway Pressure
01/2023 - 11/2020
1
Immunotherapy
02/2024
1
Extracorporeal Membrane Oxygenation
01/2022
1
Induction Chemotherapy
12/2017
1
Image-Guided Radiotherapy
01/2016
1
Transcutaneous Electric Nerve Stimulation (TENS)
12/2012